Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1996 Dec 24;93(26):15364-9.
doi: 10.1073/pnas.93.26.15364.

Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle

O E Rooyackers  1 , D B Adey, P A Ades, K S Nair
Affiliations
Comparative Study

Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle

O E Rooyackers et al. Proc Natl Acad Sci U S A. .

Abstract

A progressive decline in muscle performance in the rapidly expanding aging population is causing a dramatic increase in disability and health care costs. A decrease in muscle endurance capacity due to mitochondrial decay likely contributes to this decline in muscle performance. We developed a novel stable isotope technique to measure in vivo rates of mitochondrial protein synthesis in human skeletal muscle using needle biopsy samples and applied this technique to elucidate a potential mechanism for the age-related decline in the mitochondrial content and function of skeletal muscle. The fractional rate of muscle mitochondrial protein synthesis in young humans (24 +/- 1 year) was 0.081 +/- 0.004%.h-1, and this rate declined to 0.047 +/- 0.005%.h-1 by middle age (54 +/- 1 year; P < 0.01). No further decline in the rate of mitochondrial protein synthesis (0.051 +/- 0.004%.h-1) occurred with advancing age (73 +/- 2 years). The mitochondrial synthesis rate was about 95% higher than that of mixed protein in the young, whereas it was approximately 35% higher in the middle-aged and elderly subjects. In addition, decreasing activities of mitochondrial enzymes were observed in muscle homogenates (cytochrome c oxidase and citrate synthase) and in isolated mitochondria (citrate synthase) with increasing age, indicating declines in muscle oxidative capacity and mitochondrial function, respectively. The decrease in the rates of mitochondrial protein synthesis is likely to be responsible for this decline in muscle oxidative capacity and mitochondrial function. These changes in muscle mitochondrial protein metabolism may contribute to the age-related decline in aerobic capacity and muscle performance.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship between VO2max expressed per kilogram of muscle mass and age. In both male (y = −0.85 + 122.3; r2 = 0.72) and female (y = −0.85 + 123.1; r2 = 0.68) subjects, VO2max per kilogram of muscle decreased significantly with age (P < 0.0001).
Figure 2
Figure 2
Relationship between tissue (muscle homogenate) activities of cytochrome c oxidase and citrate synthase and age. Male and female subjects are presented as one group for each enzyme. Both activities of cytochrome c oxidase (y = −0.72x + 142.8; r2 = 0.22) and citrate synthase (y = −1.01x + 232.6; r2 = 0.20) decreased significantly with increasing age (respectively, P < 0.0017 and P < 0.0033).
Figure 3
Figure 3
Fractional synthesis rates (FSR) of skeletal muscle mitochondrial protein using plasma [13C]KIC (A) and tissue fluid [13C]leucine (B) as precursor pool enrichment, and as a percentage of mixed protein synthesis rates (C) in young, middle-aged, and old human subjects. Because no gender differences were observed, the male and female subjects are presented as one group. ∗, P < 0.05; ∗∗, P < 0.01 versus young.
Figure 4
Figure 4
Relationship between VO2max expressed per kilogram of muscle mass and tissue activities of cytochrome c oxidase (A) and citrate synthase (B).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Davies C T M, Thomas D O, White M J. Acta Med Scand Suppl. 1986;711:219–226. - PubMed
    1. Evans W J. J Gerontol. 1995;50:5–8. - PubMed
    1. Hurley B F. J Gerontol. 1995;50:41–44. - PubMed
    1. Dutta C, Hadley E C. J Gerontol. 1995;50:1–4. - PubMed
    1. Schneider E L, Guralnik J M. J Am Med Assoc. 1990;263:2335–2340. - PubMed

Publication types

MeSH terms

Substances